Parent Page: Departments & Centers id: 26023 Active Page: Gary Raskobid:26282
Gary Raskob

Senior Vice President and Provost, Regents Professor

Gary E. Raskob, Ph.D.

Contact Information

Phone: (405) 271-2201

Office: Hudson College of Public Health

801 NE 13th St, Room 128

Post Office Box 26901

Oklahoma City, OK 73104



Dr. Gary Raskob is the Interim Senior Vice President and Provost at the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, with overall responsibility for the educational and research programs of its seven colleges, and the Stephenson Cancer Center and the Harold Hamm Diabetes Center. He also serves on the Boards of the OU Health system and the University Hospitals Authority and Trust.

Dr. Raskob has academic appointments in the College of Public Health, and the College of Medicine, as a Regents Professor of Epidemiology and Medicine. He began his career at the OU Health Sciences Center in 1991. His research and scholarly interests are in the prevention and treatment of deep-vein thrombosis and pulmonary embolism; clinical trials and antithrombotic drug development; evidence-based medicine and public health; and the translation of research evidence into practice.

Dr. Raskob has participated extensively in clinical practice guideline development for several specialty organizations including the American Society of Hematology (ASH), the American College of Chest Physicians (ACCP), the American Thoracic Society (ATS), and the American Society of Clinical Oncology (ASCO). He also served as a member of the external advisory panel on thrombosis and hemostasis for the National Heart, Lung and Blood Institute (NHLBI), and as an advisor on blood disorders to the Centers for Disease Control and Prevention (CDC). He was the inaugural Chair of the Steering Committee for the World Thrombosis Day initiative of the International Society in Thrombosis and Haemostasis (ISTH), from 2013 through 2019, and he currently serves on the Board of Directors for the National Blood Clot Alliance (NBCA), the major patient advocacy organization in the United States for patients with venous thrombosis and pulmonary embolism. He is author or co-author of more than 200 publications on the prevention, diagnosis and treatment of thromboembolic disease, including 21 articles in the New England Journal of Medicine.

Dr. Raskob is a past Chair of the Board of Directors for the Association of Schools and Programs of Public Health, the organization which represents more than 100 universities in the US and globally with accredited schools and programs in public health. He is active in public health service in his community, and is an immediate past Chair of the Oklahoma City-County Board of Health, which has oversight responsibility for the health department serving the 1.3 million residents of Oklahoma City-County.

Dr. Raskob received his PhD in pharmaceutical sciences from the University of Oklahoma, a Master of Science (MSc) degree in clinical epidemiology and health research methodology from McMaster University in Hamilton, Canada, and a Bachelor of Science degree in pharmacology from the University of Toronto, Canada.



  • PhD, Pharmaceutical Sciences, University of Oklahoma, 1999
  • MS, Clinical Epidemiology and Health Research Methodology, McMaster University, 1985
  • BS, Pharmacology, University of Toronto, 1982



  • Chair, Oklahoma City-County Board of Health, 2017present
  • Dean, Hudson College of Public Health, University of Oklahoma Health Sciences Center, 20022021
  • Professor, Department of Biostatistics and Epidemiology, and Department of Medicine, University of Oklahoma Health Sciences Center, 2000present
  • Chair, Steering Committee, World Thrombosis Day, International Society on Thrombosis and Haemostasis, 20132018
  • Chair, Scientific Committee on Thrombosis and Vascular Biology, American Society of Hematology, 2014              
  • Vice Chair, Oklahoma City - County Board of Health, 2014              
  • Regents Professorship, University of Oklahoma, 2014
  • Associate Vice President for Clinical Research, University of Oklahoma Health Sciences Center, 2000–2008
  • Samuel Roberts Noble Foundation Presidential Professorship, 19992003
  • Associate Professor, Department of Biostatistics and Epidemiology, and Department of Medicine, University of Oklahoma Health Sciences Center, 19962000
  • Provost Research Award (senior faculty), 1997 
  • Assistant Professor, Department of Biostatistics and Epidemiology, and Department of Medicine, University of Oklahoma Health Sciences Center, 19921996                       


  • BSE 5153 Clinical Trials
  • PHAR 7152 Drug Study Design
  • BSE 5113 Principles of Epidemiology
  • BSE 5193 Intermediate Epidemiology
  • BSE 5033 Overview of Public Health
  • BSE 5960 Contemporary Topics in Public Health
  • Undergraduate Course HON 2973 Perspectives in Public Health
  • Undergraduate Course PHCH 2013 Introduction to Public Health
  • Undergraduate Course PHCH 3213 Health, Policy, Law and Ethics
  • Undergraduate Course PHCH 3513 Public Health and Healthcare Systems


Research Interests:

  • Clinical studies to improve the diagnosis of Venous Thromboembolism (VTE)
  • Evidence-based practice guidelines for antithrombotic therapy and diagnosis of VTE
  • Treatment of Cancer-Associated Venous Thromboembolism
  • Prevention, diagnosis, and treatment of deep-vein thrombosis and pulmonary embolism
  • Translation of research evidence into practice and health policy


Link to Dr. Raskob's current publications

Select publications:

  1. Raskob, Gary (Editor). Oklahoma Pride: Working Together for the Well-being of All Oklahomans. Oklahoma City, OK: Full Circle Bookstore; 2021.
  2. Raskob, Gary; Spyropoulos, Alex; Cohen, Alexander; Weitz, Jeffrey; Ageno, Walter; Sanctis, Yoriko; Lu, Wentao; Xu, Jianfeng; Albanese, John; Sugarmann, Chiara; Weber, Traci; Lipardi, Concetta; Spiro, Theodore; Barnathan, Elliot. Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients. J Am Heart Assoc. 2021;10(5):e019459. doi:10.1161/JAHA.120.019459
  3. Wendelboe, Aaron; Campbell, Janis; Ding, Kai; Bratzler, Dale; Beckman, Michele; Reyes, Nimia; Raskob, Gary. Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma. Thromb Haemost. 2021;121(6):816-825. doi:10.1055/s-0040-1722189
  4. O’Connell, Casey; Escalante, Carmen; Goldhaber, Samuel; McBane, Robert; Connors, Jean; Raskob, Gary. Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats. Oncologist. 2021;26(1):e8-e16. doi:10.1002/onco.13584
  5. Spyropoulos, Alex; Ageno, Walter; Albers, Gregory; Elliott, C.; Halperin, Jonathan; Hiatt, William; Maynard, Gregory; Steg, P.; Weitz, Jeffrey; Lu, Wentao; Spiro, Theodore; Barnathan, Elliot; Raskob, Gary. Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients. J Am Coll Cardiol. 2020;75(25):3140-3147. doi:10.1016/j.jacc.2020.04.071